The long term objective of this proposal is to increase our understanding of immune responses to polysaccharide antigens. To accomplish this goal, we will measure serum antibody responses to bacterial PS vaccines, and in vitro Ig production by mitogen stimulated lymphocytes from normal and abnormal subjects.
In Aim 1, we will investigate the immunologic and genetic basis of """"""""vaccine failure"""""""" in patients who develop Haemophilus influenzae type b (Hib) disease despite previous vaccination with Hib polysaccharide (PS) vaccine. This group previously has been shown to have impaired serum antibody responses to Hib PS despite having normal concentrations of serum Ig. The techniques we propose to use to evaluate these patients include: a. measurement of their IgM, IgG and IgG subclass-specific antibody responses to immunization with different bacterial PS antigens presented as isolated PS vaccine (T-independent) or as a covalent PS-protein conjugate (T-dependent); b. measurement of their IgG antibody responses to Hib outer membrane proteins following recovery from Hib disease; c. measurement of Ig secretion in vitro by mitogen- stimulated lymphocytes; and d. determination of the frequencies of different allotype haplotypes previously associated with altered risk of Hib PS vaccine failure. The results of these studies will define the range of the immunologic deficits present in these children, and the extent to which genes in linkage disequilibrium with Ig allotypes contribute to vaccine failure.
In Aim 2, we will immunize healthy adults with meningococcal A and C PS and tetanus toxoid vaccines and compare their respective IgG2 antibody responses in relation to G2m(23) allotype status to determine whether the relationship observed previously in normal individuals between this allotype and the magnitude of the IgG2 antibody responses to Hib PS is specific or extends to IgG2 responses to other PS antigens or to protein antigens. We also will compare the amount of IgG2 produced in vitro by mitogen-stimulated lymphocytes from G2m(23)-positive and negative subjects in an effort to develop an in vitro assay to investigate T and B cell interactions contributing to this allotype association. Finally, in Aim 3, we will compare the relative bactericidal and opsonic activities of IgG1, IgG2 and IgG3 antibodies to Hib PS. Our previous data suggest that genetic factor as well as age of immunization and type of vaccine influence the IgG subclass distribution of serum antibody to Hib PS. The results of these studies will indicate whether individuals with similar levels of total IgG antibody but different subclass distributions are equally protected against Hib disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI017962-08
Application #
3127565
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1981-07-01
Project End
1993-08-31
Budget Start
1989-09-01
Budget End
1990-08-31
Support Year
8
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Lottenbach, Kathleen R; Granoff, Dan M; Barenkamp, Stephen J et al. (2004) Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population. J Am Geriatr Soc 52:1883-7
Kantor, E; Luxenberg, J S; Lucas, A H et al. (1997) Phase I study of the immunogenicity and safety of conjugated Hemophilus influenzae type b vaccines in the elderly. Vaccine 15:129-32
Levine, O S; Granoff, D M; Lagos, R et al. (1997) Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age. Vaccine 15:325-8
Lucas, A H; Granoff, D M (1995) Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates. J Immunol 154:4195-202
Granoff, D M; Kelsey, S K; Bijlmer, H A et al. (1995) Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease. Clin Diagn Lab Immunol 2:574-82
Granoff, D M; Lucas, A H (1995) Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory. Ann N Y Acad Sci 754:278-88
Azmi, F H; Lucas, A H; Spiegelberg, H L et al. (1995) Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain. Infect Immun 63:1906-13
Mandrell, R E; Azmi, F H; Granoff, D M (1995) Complement-mediated bactericidal activity of human antibodies to poly alpha 2-->8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. J Infect Dis 172:1279-89
Azmi, F H; Lucas, A H; Raff, H V et al. (1994) Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1. Infect Immun 62:1776-86
Granoff, D M; Holmes, S J; Belshe, R B et al. (1994) Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. JAMA 272:1116-21

Showing the most recent 10 out of 61 publications